ALBANY, N.Y., April 1, 2021 /PRNewswire/ -- Self-injection devices have become a mainstay of numerous infusion therapies for long-term management of chronic conditions, mainly by making subcutaneous ...

Credit: Mallinckrodt. Acthar Gel single-dose prefilled SelfJect Injector is supplied as 40 USP Units/0.5mL and 80 USP Units/mL dosage strengths. The new injector device is intended to simplify the ...

The new injector device is intended to allow adults to self-administer Acthar Gel with fewer steps. The Food and Drug Administration (FDA) has approved a new single-dose prefilled SelfJect ™ Injector ...

With training and planning, self-injecting your rheumatoid arthritis medication may be easier than you think.

Pharma giants from Johnson & Johnson to Novartis to Roche, looking for edges in speed and convenience, have unveiled self-injection options to replace intravenous infusions in the fields of cancer, ...

Cabotegravir and rilpivirine (cabenuva), the only complete HIV treatment regimen delivered by injection, could be given by intramuscular injection to the thigh rather than the gluteal muscles, ...

– Acthar Gel is the first and only medication in its class of adrenocorticotropic hormone products available in a self-injection device to treat a range of chronic and acute inflammatory and ...

The advent of large-protein biologics enabled the creation of breakthrough treatments for many chronic conditions, and this represents a multi-billion-dollar market. However, challenges exist with the ...